DocCheck Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

DocCheck has a total shareholder equity of €37.4M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €55.7M and €18.4M respectively. DocCheck's EBIT is €3.7M making its interest coverage ratio -4. It has cash and short-term investments of €19.5M.

Anahtar bilgiler

0%

Borç/özkaynak oranı

€0

Borç

Faiz karşılama oranı-4x
Nakit€19.47m
Eşitlik€37.36m
Toplam yükümlülükler€18.37m
Toplam varlıklar€55.72m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

Apr 19
We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Aug 04
DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

May 20
Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Nov 06
The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

Mar 03
Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Jan 18
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Aug 26
Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

May 02
Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Apr 18
Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Mar 23
Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Mar 04
Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Feb 14
Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Jan 27
Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

Jan 10
Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Dec 22
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Dec 07
What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 22
DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: AJ91's short term assets (€34.9M) exceed its short term liabilities (€13.6M).

Uzun Vadeli Yükümlülükler: AJ91's short term assets (€34.9M) exceed its long term liabilities (€4.8M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: AJ91 is debt free.

Borcun Azaltılması: AJ91 has no debt compared to 5 years ago when its debt to equity ratio was 0.1%.

Borç Kapsamı: AJ91 has no debt, therefore it does not need to be covered by operating cash flow.

Faiz Kapsamı: AJ91 has no debt, therefore coverage of interest payments is not a concern.


Bilanço


Sağlıklı şirketleri keşfedin